Memory of extracellular adenosine A(2A) purinergic receptor-mediated signaling in murine T cells

被引:157
作者
Koshiba, M [1 ]
Kojima, H [1 ]
Huang, S [1 ]
Apasov, S [1 ]
Sitkovsky, MV [1 ]
机构
[1] NIAID,IMMUNOL LAB,NIH,BETHESDA,MD 20892
关键词
D O I
10.1074/jbc.272.41.25881
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of extracellular and intracellular adenosine (Ado) under hypoxic conditions or in the absence of adenosine deaminase results in lymphocyte depletion and in severe combined immunodeficiency, which are currently explained by direct intracellular lymphotoxicity of Ado metabolites. In support of the alternative, ''signaling'' mechanism, we show that extracellular Ado (extAdo) suppresses all tested T cell receptor (TCR)triggered effector functions of T Lymphocytes including the TCR-triggered Fast mRNA up-regulation in cytotoxic T lymphocytes. Strong evidence against the intracellular lymphotoxicity of Ado (and in support of the signaling model) is provided by abrogation of TCR-triggered growth inhibition in Ado exposed T cells. The brief exposure to Ado was sufficient to observe inhibition of TCR-triggered effector functions. The ''memory'' of T cells to exposure to extAdo is best explained by sustained increases in cAMP. Selective agonist (CGS21680) and antagonist (ZM241385) of A(2A) adenosine receptor were used in functional assays and cDNA probes for different sybtypes of adenosine receptors were used in Northern blot studies. A(2A) receptors are identified as the predominantly expressed subtype of G(s)-coupled Ado receptors in T cells, The demonstration of cross-talk between the A(2A) receptors and TCR in both directions support the possible role of A(2A) receptors in mechanisms of extAdo-mediated immunosuppression in vivo under adenosine deaminase deficiency and hypoxic conditions in, e.g., solid tumors.
引用
收藏
页码:25881 / 25889
页数:9
相关论文
共 41 条
[1]   ROLE OF EXTRACELLULAR ATP AND P1 AND P2 CLASSES OF PURINERGIC RECEPTORS IN T-CELL DEVELOPMENT AND CYTOTOXIC T-LYMPHOCYTE EFFECTOR FUNCTIONS [J].
APASOV, S ;
KOSHIBA, M ;
REDEGELD, F ;
SITKOVSKY, MV .
IMMUNOLOGICAL REVIEWS, 1995, 146 :5-19
[2]  
Apasov SG, 1997, J IMMUNOL, V158, P5095
[3]   CELL-GROWTH CYCLE BLOCK OF T-CELL HYBRIDOMAS UPON ACTIVATION WITH ANTIGEN [J].
ASHWELL, JD ;
CUNNINGHAM, RE ;
NOGUCHI, PD ;
HERNANDEZ, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) :173-194
[4]  
BLACKBURN MR, 1996, J BIOL CHEM, V271, P15208
[5]   THE ANTIINFLAMMATORY EFFECTS OF AN ADENOSINE KINASE INHIBITOR ARE MEDIATED BY ADENOSINE [J].
CRONSTEIN, BN ;
NAIME, D ;
FIRESTEIN, G .
ARTHRITIS AND RHEUMATISM, 1995, 38 (08) :1040-1045
[6]  
GIBLETT ER, 1972, LANCET, V2, P1067
[7]  
HENKART PA, 1992, CYTOTOXIC CELLS RECO, P153
[8]  
Hershfield MS, 1995, METABOLIC MOL BASES, V2, P1725
[9]   ADENOSINE-DEAMINASE DEFICIENCY - MOLECULAR-BASIS AND RECENT DEVELOPMENTS [J].
HIRSCHHORN, R .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 76 (03) :S219-S227
[10]   ADENOSINE AS A POSSIBLE INHIBITOR OF KILLER T-CELL ACTIVATION IN THE MICROENVIRONMENT OF SOLID TUMORS [J].
HOSKIN, DW ;
REYNOLDS, T ;
BLAY, J .
INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (06) :854-855